Vena Caval Flow Regurgitation at Four-dimensional Flow MRI: A New Sign for a Hemodynamic Phenotype of Chronic Obstructive Pulmonary Disease and Emphysema?

Published Online:https://doi.org/10.1148/radiol.2019191255
Free first page

References

  • 1. Azarine A, Garçon P, Stansal A, et al. Four-dimensional Flow MRI: Principles and Cardiovascular Applications. RadioGraphics 2019;39(3):632–648.
  • 2. Rahman O, Markl M, Balte P, et al. Reproducibility and changes in vena caval blood flow by using 4D flow MRI in pulmonary emphysema and chronic obstructive pulmonary disease (COPD): the Multi-Ethnic Study of Atherosclerosis (MESA) COPD sub-study. Radiology 2019;292:585–594.
  • 3. Schäfer M, Humphries S, Stenmark KR, et al. 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-to-moderate chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Imaging 2018;19(4):415–424.
  • 4. Gagnon P, Guenette JA, Langer D, et al. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:187–201.
  • 5. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362(3):217–227.
  • 6. Barr RG. Rethinking Chronic Obstructive Pulmonary Disease. Chronic Pulmonary Insufficiency and Combined Cardiopulmonary Insufficiency. Ann Am Thorac Soc 2018;15(Supplement_1):S30–S34.
  • 7. Aaron CP, Hoffman EA, Lima JAC, et al. Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study. PLoS One 2017;12(4):e0176180.
  • 8. Jörgensen K, Müller MF, Nel J, Upton RN, Houltz E, Ricksten SE. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 2007;131(4):1050–1057.
  • 9. Vogel-Claussen J, Schönfeld CO, Kaireit TF, et al. Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial. Am J Respir Crit Care Med 2019;199(9):1086–1096.
  • 10. Hohlfeld JM, Vogel-Claussen J, Biller H, et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 2018;6(5):368–378.

Article History

Received: June 3 2019
Revision requested: June 7 2019
Revision received: June 8 2019
Accepted: June 13 2019
Published online: July 23 2019
Published in print: Sept 2019